spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Immune system, antitumor protein PDB id
1jh5
Jmol
Contents
Protein chains
(+ 4 more) 144 a.a. *
* Residue conservation analysis
PDB id:
1jh5
Name: Immune system, antitumor protein
Title: Crystal structure of stall-1 of tnf family ligand
Structure: Tumor necrosis factor ligand superfamily member 1 chain: a, b, c, d, e, f, g, h, i, j. Fragment: stall-1, soluble part of tall-1. Synonym: tnf family ligand. Tnf-and apol-related leukocyte ligand 1. Tall-1. B lymphocyte stimulator. Blys. B cell-act factor. Tumor necrosis factor (ligand) superfamily, member engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: 60mer (from PQS)
Resolution:
3.00Å     R-factor:   0.236     R-free:   0.252
Authors: Y.Liu,L.Xu,N.Opalka,H.-B.Shu,G.Zhang
Key ref:
Y.Liu et al. (2002). Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell, 108, 383-394. PubMed id: 11853672 DOI: 10.1016/S0092-8674(02)00631-1
Date:
27-Jun-01     Release date:   08-Feb-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9Y275  (TN13B_HUMAN) -  Tumor necrosis factor ligand superfamily member 13B
Seq:
Struc:
285 a.a.
144 a.a.
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   1 term 
  Biological process     immune response   1 term 
  Biochemical function     protein binding     2 terms  

 

 
DOI no: 10.1016/S0092-8674(02)00631-1 Cell 108:383-394 (2002)
PubMed id: 11853672  
 
 
Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands.
Y.Liu, L.Xu, N.Opalka, J.Kappler, H.B.Shu, G.Zhang.
 
  ABSTRACT  
 
TALL-1/BAFF/BLyS was recently identified as a member of the tumor necrosis factor (TNF) ligand family. The crystal structure of the functional soluble TALL-1 (sTALL-1) has been determined at 3.0 A. sTALL-1 forms a virus-like assembly with 200 A diameter in the crystals, containing 60 sTALL-1 monomers. The cluster formation is mediated by a "flap" region of the sTALL-1 monomer. The virus-like assembly was also detected in solution using gel filtration and electron microscopy. Deletion of the flap region disrupted the formation of the virus-like assembly. The mutant sTALL-1 still bound its receptor but could not activate NF-kappaB and did not stimulate B lymphocyte proliferation. Finally, we found the virus-like cluster of sTALL-1 exists in physiological condition. We propose that this virus-like assembly of sTALL-1 is the functional unit for TALL-1 in vivo.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. The Relative Position of an Asymmetry Unit in the Cluster and Overall Structures of the Cluster at Different Orientations(A) The ten monomers (yellow) in the asymmetric unit, which generate the left 50 monomers (colored gray) through crystallographic symmetry (P6[3]22) to form the virus-like cluster with total of 60 monomers.(B) The structure of virus-like cluster (T = 1) looking down from the local five-fold symmetry, and (C) looking down from the three-fold symmetry. All monomers are colored according to chains as default set in RIBBON (Carson, 1987).
Figure 7.
Figure 7. Structure-Based Sequence Alignments of TNF Ligand Family Members at the Region Spanning β Strands D and EConserved hydrophobic residues are bold. Sequence source is from Locksley et al., 2001.
 
  The above figures are reprinted by permission from Cell Press: Cell (2002, 108, 383-394) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21287546 C.Bossen, A.Tardivel, L.Willen, C.A.Fletcher, M.Perroud, F.Beermann, A.G.Rolink, M.L.Scott, F.Mackay, and P.Schneider (2011).
Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses.
  Eur J Immunol, 41, 787-797.  
21102426 L.Zhang, Y.Jiang, Y.Zheng, Y.Zeng, Z.Yang, G.Huang, D.Liu, M.Gao, X.Shen, G.Wu, X.Yan, and F.He (2011).
Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.
  Leukemia, 25, 331-340.  
20663918 D.A.Turner, P.Paszek, D.J.Woodcock, D.E.Nelson, C.A.Horton, Y.Wang, D.G.Spiller, D.A.Rand, M.R.White, and C.V.Harper (2010).
Physiological levels of TNFalpha stimulation induce stochastic dynamics of NF-kappaB responses in single living cells.
  J Cell Sci, 123, 2834-2843.  
20302641 S.R.Dillon, B.Harder, K.B.Lewis, M.D.Moore, H.Liu, T.R.Bukowski, N.B.Hamacher, M.M.Lantry, M.Maurer, C.M.Krejsa, J.L.Ellsworth, S.Pederson, K.B.Elkon, M.H.Wener, M.Dall'Era, and J.A.Gross (2010).
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.
  Arthritis Res Ther, 12, R48.  
19346949 C.Daridon, G.R.Burmester, and T.Dörner (2009).
Anticytokine therapy impacting on B cells in autoimmune diseases.
  Curr Opin Rheumatol, 21, 205-210.  
19557629 G.Ferrer, K.Hodgson, E.Montserrat, and C.Moreno (2009).
B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity.
  Leuk Lymphoma, 50, 1075-1082.  
19411764 M.P.Cancro, D.P.D'Cruz, and M.A.Khamashta (2009).
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
  J Clin Invest, 119, 1066-1073.  
18155417 A.Binard, L.Le Pottier, A.Saraux, V.Devauchelle-Pensec, J.O.Pers, and P.Youinou (2008).
Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
  J Autoimmun, 30, 63-67.  
17942754 C.Bossen, T.G.Cachero, A.Tardivel, K.Ingold, L.Willen, M.Dobles, M.L.Scott, A.Maquelin, E.Belnoue, C.A.Siegrist, S.Chevrier, H.Acha-Orbea, H.Leung, F.Mackay, J.Tschopp, and P.Schneider (2008).
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
  Blood, 111, 1004-1012.  
18514565 F.Mackay, and P.Schneider (2008).
TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
  Cytokine Growth Factor Rev, 19, 263-276.  
18515426 H.T.Jäälinoja, E.Roine, P.Laurinmäki, H.M.Kivelä, D.H.Bamford, and S.J.Butcher (2008).
Structure and host-cell interaction of SH1, a membrane-containing, halophilic euryarchaeal virus.
  Proc Natl Acad Sci U S A, 105, 8008-8013.  
18378892 Z.Zhou, X.Song, A.Berezov, G.Zhang, Y.Li, H.Zhang, R.Murali, B.Li, and M.I.Greene (2008).
Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.
  Proc Natl Acad Sci U S A, 105, 5465-5470.  
17492055 L.Garibyan, A.A.Lobito, R.M.Siegel, M.E.Call, K.W.Wucherpfennig, and R.S.Geha (2007).
Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
  J Clin Invest, 117, 1550-1557.  
16914324 C.Bossen, and P.Schneider (2006).
BAFF, APRIL and their receptors: structure, function and signaling.
  Semin Immunol, 18, 263-275.  
16357320 D.Bischof, S.F.Elsawa, G.Mantchev, J.Yoon, G.E.Michels, A.Nilson, S.L.Sutor, J.L.Platt, S.M.Ansell, G.von Bulow, and R.J.Bram (2006).
Selective activation of TACI by syndecan-2.
  Blood, 107, 3235-3242.  
16902849 H.Gao, W.Fu, R.Li, L.Chen, Q.Ji, L.Zhang, G.Huang, and F.He (2006).
Expression and purification of a soluble B lymphocyte stimulator mutant modified with the T-helper cell epitope.
  Biotechnol Lett, 28, 1649-1654.  
16557636 L.L.Kiessling, J.E.Gestwicki, and L.E.Strong (2006).
Synthetic multivalent ligands as probes of signal transduction.
  Angew Chem Int Ed Engl, 45, 2348-2368.  
16604261 Q.Shen, S.X.Li, F.H.Fu, Q.S.Yuan, and Y.Gong (2006).
Two observed regions in B lymphocyte stimulator important for its biological activity.
  Acta Biochim Biophys Sin (Shanghai), 38, 227-232.  
15886118 P.Schneider (2005).
The role of APRIL and BAFF in lymphocyte activation.
  Curr Opin Immunol, 17, 282-289.  
16320342 R.H.Carter, H.Zhao, X.Liu, M.Pelletier, W.Chatham, R.Kimberly, and T.Zhou (2005).
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
  Arthritis Rheum, 52, 3943-3954.  
15542592 S.G.Hymowitz, D.R.Patel, H.J.Wallweber, S.Runyon, M.Yan, J.Yin, S.K.Shriver, N.C.Gordon, B.Pan, N.J.Skelton, R.F.Kelley, and M.A.Starovasnik (2005).
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
  J Biol Chem, 280, 7218-7227.
PDB codes: 1xu1 1xu2 1xut
16184518 S.Mintz, A.Shulman-Peleg, H.J.Wolfson, and R.Nussinov (2005).
Generation and analysis of a protein-protein interface data set with similar chemical and spatial patterns of interactions.
  Proteins, 61, 6.  
15382264 T.J.Fleming, M.Sachdeva, M.Delic, J.Beltzer, C.R.Wescott, M.Devlin, R.C.Lander, A.E.Nixon, V.Roschke, D.M.Hilbert, and D.J.Sexton (2005).
Discovery of high-affinity peptide binders to BLyS by phage display.
  J Mol Recognit, 18, 94.  
16276047 T.Matsushita, and S.Sato (2005).
[The role of BAFF in autoimmune diseases]
  Nihon Rinsho Meneki Gakkai Kaishi, 28, 333-342.  
16264328 U.Salzer, and B.Grimbacher (2005).
TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
  Curr Opin Allergy Clin Immunol, 5, 496-503.  
14764606 D.R.Patel, H.J.Wallweber, J.Yin, S.K.Shriver, S.A.Marsters, N.C.Gordon, M.A.Starovasnik, and R.F.Kelley (2004).
Engineering an APRIL-specific B cell maturation antigen.
  J Biol Chem, 279, 16727-16735.  
15093829 G.Zhang (2004).
Tumor necrosis factor family ligand-receptor binding.
  Curr Opin Struct Biol, 14, 154-160.  
15140054 K.Koskela, P.Nieminen, P.Kohonen, H.Salminen, and O.Lassila (2004).
Chicken B-cell-activating factor: regulator of B-cell survival in the bursa of fabricius.
  Scand J Immunol, 59, 449-457.  
15546397 M.P.Cancro (2004).
The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.
  Immunol Rev, 202, 237-249.  
15084273 R.Lesley, Y.Xu, S.L.Kalled, D.M.Hess, S.R.Schwab, H.B.Shu, and J.G.Cyster (2004).
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.
  Immunity, 20, 441-453.  
15574324 S.D.Benson, J.K.Bamford, D.H.Bamford, and R.M.Burnett (2004).
Does common architecture reveal a viral lineage spanning all three domains of life?
  Mol Cell, 16, 673-685.  
15161425 W.Stohl (2004).
Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders.
  Expert Opin Ther Targets, 8, 177-189.  
12867412 A.L.Gavin, D.Aït-Azzouzene, C.F.Ware, and D.Nemazee (2003).
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.
  J Biol Chem, 278, 38220-38228.  
  12787568 F.Mackay, and C.Ambrose (2003).
The TNF family members BAFF and APRIL: the growing complexity.
  Cytokine Growth Factor Rev, 14, 311-324.  
12427767 F.Mackay, P.Schneider, P.Rennert, and J.Browning (2003).
BAFF AND APRIL: a tutorial on B cell survival.
  Annu Rev Immunol, 21, 231-264.  
12715002 H.M.Kim, K.S.Yu, M.E.Lee, D.R.Shin, Y.S.Kim, S.G.Paik, O.J.Yoo, H.Lee, and J.O.Lee (2003).
Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
  Nat Struct Biol, 10, 342-348.
PDB codes: 1otz 1p0t
12796483 M.Pelletier, J.S.Thompson, F.Qian, S.A.Bixler, D.Gong, T.Cachero, K.Gilbride, E.Day, M.Zafari, C.Benjamin, L.Gorelik, A.Whitty, S.L.Kalled, C.Ambrose, and Y.M.Hsu (2003).
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF.
  J Biol Chem, 278, 33127-33133.  
14732928 R.L.Rich, and D.G.Myszka (2003).
A survey of the year 2002 commercial optical biosensor literature.
  J Mol Recognit, 16, 351-382.  
  14656435 S.G.Hymowitz, D.M.Compaan, M.Yan, H.J.Wallweber, V.M.Dixit, M.A.Starovasnik, and A.M.de Vos (2003).
The crystal structures of EDA-A1 and EDA-A2: splice variants with distinct receptor specificity.
  Structure, 11, 1513-1520.
PDB code: 1rj8
12556207 S.L.Kalled, C.Ambrose, and Y.M.Hsu (2003).
BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders.
  Expert Opin Ther Targets, 7, 115-123.  
12721620 Y.Liu, X.Hong, J.Kappler, L.Jiang, R.Zhang, L.Xu, C.H.Pan, W.E.Martin, R.C.Murphy, H.B.Shu, S.Dai, and G.Zhang (2003).
Ligand-receptor binding revealed by the TNF family member TALL-1.
  Nature, 423, 49-56.
PDB codes: 1oqd 1oqe
11862220 D.A.Oren, Y.Li, Y.Volovik, T.S.Morris, C.Dharia, K.Das, O.Galperina, R.Gentz, and E.Arnold (2002).
Structural basis of BLyS receptor recognition.
  Nat Struct Biol, 9, 288-292.
PDB code: 1kxg
12094221 F.Mackay, and J.L.Browning (2002).
BAFF: a fundamental survival factor for B cells.
  Nat Rev Immunol, 2, 465-475.  
11943541 M.C.Dagher (2002).
An active cytokine with a virus-like structure.
  Trends Biochem Sci, 27, 175-176.  
12192248 W.Stohl (2002).
Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein.
  Curr Opin Rheumatol, 14, 522-528.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.